- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Corporate and Securities Litigation
- E-Discovery
- Global Construction and Infrastructure Disputes
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Events 162 results
Webinar
Februar 25, 2026
Data Dividends vs. Red Lines: Navigating EU Data Laws and Cyber Threats in Pharma’s Data‑Driven Era
Webinar
Februar 24, 2026
Reading the Tea Leaves: Top 10 Enforcement and Regulatory Risks for Device Makers in 2026
Webinar
Februar 18, 2026
Is the NSA IDR Process Dead?
Webinar
Januar 29, 2026
The Revision of the EU General Pharmaceutical Legislation
Webinar
Januar 28, 2026
Hot Privacy and Security Topics for 2026
Webinar
Januar 28, 2026
Drug & Device Advertising Year in Review: Lessons from 2025 FDA Enforcement & Key Developments
Webinar
Januar 21, 2026
A Review of CMS’s 2026 IPPS and OPPS Final Rules
Webinar
Januar 8, 2026
Medicare and Medicaid Demos Seek To Impose Most Favored Nation Pricing: An Overview of GLOBE, GUARD, and GENEROUS
Webinar
Dezember 18, 2025
Drug Compounding Litigation Update: Compounder Cases Against FDA and Pharma Company Cases Against Compounders
Webinar
November 20, 2025
Pricing and Reimbursement in Europe
Webinar
November 20, 2025
Data Security Incident Response: How to Plan for It, Deal With It and Survive It
Webinar
November 19, 2025
Prescription for Trouble: FDA’s “Crackdown” on Drug Ads